Topic
Opioid overdose – ED discharge instructions
💡 What You Need to Know
- Risk of Re-overdose: The effects of naloxone may wear off, and the opioid can still be active in the body, leading to a second overdose. This risk is highest in the first few hours after discharge.
- Naloxone Availability: It is crucial to have naloxone (Narcan or Kloxxado) readily available at home and to ensure family or friends know how to administer it.
- Follow-up Care is Essential: This overdose is a critical indicator for immediate follow-up with addiction treatment services, mental health support, and primary care.
- Avoid Solo Use: Never use opioids alone. Always ensure someone else is present who can administer naloxone and call for help if needed.
🤒 Associated Symptoms
- Signs of Re-overdose: Watch for pinpoint pupils, slow or shallow breathing (less than 10 breaths per minute), blue lips or fingertips, unresponsiveness, or inability to be woken up.
- Opioid Withdrawal Symptoms: As naloxone wears off or if opioid use is stopped abruptly, symptoms like severe muscle aches, nausea, vomiting, diarrhea, agitation, anxiety, and goosebumps may occur. These warrant medical attention.
- Persistent Drowsiness: If the patient remains excessively drowsy, confused, or difficult to arouse after naloxone administration, seek immediate medical evaluation.
- Respiratory Distress: Any difficulty breathing, gasping for air, or noisy breathing requires urgent re-evaluation.
🛡 Crucial Precautions
- Do Not Use Opioids: Strictly avoid using any opioids, sedatives, or alcohol after discharge, as this significantly increases the risk of another overdose.
- Naloxone Administration: If signs of re-overdose appear, administer naloxone immediately and call 911 (or your local emergency number) even if the patient seems to improve.
- Constant Supervision: A responsible adult must stay with the patient for at least 24-48 hours post-overdose to monitor for recurrent symptoms and administer naloxone if necessary.
- Safe Medication Storage: All medications, especially opioids, must be stored securely to prevent accidental ingestion or misuse.
- Emergency Contact: Ensure the patient and caregiver know when and how to call emergency services (e.g., 911) for any concerning symptoms.
🍽 Dietary Directions & Restrictions
- Hydration: Encourage oral fluids like water or clear broths if the patient is fully awake and able to swallow safely.
- Light, Bland Meals: Offer easily digestible foods such as toast, crackers, or plain rice if the patient expresses hunger and has no nausea or vomiting.
- Avoid Alcohol and Sedatives: Absolutely no alcohol or other central nervous system depressants (e.g., benzodiazepines) should be consumed, as they can worsen respiratory depression and increase overdose risk.
- Monitor for Nausea/Vomiting: If nausea or vomiting persists, avoid solid foods and continue with clear liquids. Seek medical advice if severe or prolonged.
⚠️ Attendant Guidelines
- Continuous Monitoring: Observe the patient closely for at least 24-48 hours for any signs of recurrent overdose, especially changes in breathing, alertness, or pupil size.
- Naloxone Training: Ensure you are trained and comfortable administering naloxone. Know where it is stored and how to access it quickly.
- Emergency Protocol: Be prepared to call 911 immediately if the patient shows signs of re-overdose, even after administering naloxone.
- Prevent Access to Opioids: Securely remove or lock away any illicit or prescribed opioids from the patient's immediate access.
- Encourage Follow-up: Strongly encourage and assist the patient in attending all scheduled follow-up appointments for addiction treatment and medical care.
🩺 Physician's Perspective
- Opioid Use Disorder (OUD) Treatment: An opioid overdose is a medical emergency and a clear indication for immediate engagement in OUD treatment. Medication-Assisted Treatment (MAT) with buprenorphine/naloxone or naltrexone significantly reduces the risk of future overdose and improves outcomes.
- Harm Reduction Strategies: Discuss and provide resources for harm reduction, including naloxone distribution, safe injection practices (if applicable), and avoiding using alone.
- Mental Health Co-morbidity: Screen for and address co-occurring mental health conditions, as they frequently complicate OUD and recovery. Integrated care is crucial.
- Social Support: Emphasize the importance of a strong support system and connect patients with social workers or peer recovery specialists.
- Relapse Prevention: Acknowledge that relapse is part of the chronic disease of addiction and that continued support and treatment are vital for long-term recovery.
🎓 Academic & Nursing Corner
- Comprehensive Naloxone Education: Provide detailed, hands-on education to both the patient and their support person on naloxone administration, including indications, dosage, route, and post-administration actions.
- Withdrawal Symptom Management: Educate on anticipated opioid withdrawal symptoms and strategies for managing them, including the importance of seeking medical help for severe symptoms.
- Referral Coordination: Facilitate warm handoffs to addiction treatment programs, peer recovery coaches, social work, and mental health services. Ensure contact information and initial appointments are provided.
- Stigma-Informed Care: Approach patient education and discharge planning with a non-judgmental, empathetic, and trauma-informed perspective to foster trust and engagement in care.
- Post-Overdose Monitoring: Emphasize the critical need for extended post-discharge monitoring due to the potential for recurrent respiratory depression and the variable half-life of different opioids.
🔬 Clinical Reference Index
- Naloxone Pharmacodynamics: A competitive opioid receptor antagonist with a shorter half-life (30-90 minutes) than many opioids, necessitating repeat dosing and prolonged observation.
- Post-Overdose Syndrome: Potential complications include non-cardiogenic pulmonary edema, rhabdomyolysis, aspiration pneumonia, and acute kidney injury, requiring vigilant monitoring.
- Opioid Use Disorder (OUD) Criteria: Diagnosis based on DSM-5 criteria, characterized by a problematic pattern of opioid use leading to clinically significant impairment or distress.
- Medication-Assisted Treatment (MAT): Evidence-based treatment combining behavioral therapy and medications (e.g., buprenorphine/naloxone, naltrexone, methadone) to treat OUD.
- Harm Reduction Principles: Public health strategies aimed at reducing negative consequences associated with drug use, including naloxone distribution, syringe service programs, and overdose prevention sites.